Perihan Ozturk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Perihan Ozturk has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Mine Müjde Kuş
Kahramanmaraş Sütcü Imam University
10 shared publications - Ergul Belge Kurutas
Kahramanmaraş Sütçü İmam University, Faculty of Medicine, Department of Medical Biochemistry, 46050, Kahramanmaraş, Türkiye
8 shared publications - Mehmet Kamil Mülayim
Faculty of Medicine Department of Dermatology, Sütçü İmam University, Kahramanmaraş, Turkey
5 shared publications - Hülya Nazi̇k
Department of Dermatology Kahramanmaras Sutcu Imam University Kahramanmaras Turkey
4 shared publications - Mehmet Enes Güner
Faculty of Medicine, Department of Dermatology, Inonu University
4 shared publications Ergul Belge Kurutas
Department of Biochemistry, Medical Faculty, KSU, Kahramanmaras, Turkey
3 shared publications
Latest Publications
- Open Access
- 8 June 2026
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 40
Phase-specific redistribution of dermatologic diagnoses following the 2023 Kahramanmaraş Earthquakes in Türkiye: A comparative outpatient study
- 8 June 2026
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 40
Open AccessPhase-specific redistribution of dermatologic diagnoses following the 2023 Kahramanmaraş Earthquakes in Türkiye: A comparative outpatient study
- Open Access
- 31 October 2025
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 15 (4) , 6169
Predictors of Early Response and Relapse in Chronic Spontaneous Urticaria Treated with Omalizumab: The Role of Age, Sex, Disease Duration, and UAS7
Introduction: Omalizumab is an established treatment for chronic spontaneous urticaria (CSU), yet variability in therapeutic response remains a clinical challenge. Identifying baseline predictors of early response may help optimize patient selection and management strategies. Objectives: To evaluate the predictive value of age, sex, baseline disease severity, and disease duration for early response to omalizumab and to assess their relationship with relapse risk. Methods: This retrospective study included 274 patients with CSU treated with omalizumab between 2011 and 2024. Early response was defined as achieving a UAS7 score <7 at one month. Baseline variables included age, sex, UAS7, and disease duration. Binary logistic regression and ROC curve analyses were conducted to identify independent predictors of early response. Results: Among 274 patients (mean age 42.96±15.54 years; 66.4% female), early response was achieved in 37.6%. Early responders had significantly lower baseline UAS7 and shorter disease duration (both P<0.001). Logistic regression confirmed both variables as independent predictors. Age and sex were not independently associated with early response, although univariate analysis showed a higher early response rate in patients aged <45 years. ROC analysis demonstrated strong inverse predictive value for UAS7 (AUC=0.917) and disease duration (AUC=0.940). Relapse risk was significantly lower in females and patients aged <45 years. Conclusions: Lower baseline UAS7 and shorter disease duration independently predict early response to omalizumab. Younger age and female sex may be associated with lower relapse risk. These findings support earlier therapeutic intervention in patients with lower disease burden to improve outcomes.
- 31 October 2025
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 15 (4) , 6169
Open AccessPredictors of Early Response and Relapse in Chronic Spontaneous Urticaria Treated with Omalizumab: The Role of Age, Sex, Disease Duration, and UAS7
Introduction: Omalizumab is an established treatment for chronic spontaneous urticaria (CSU), yet variability in therapeutic response remains a clinical challenge. Identifying baseline predictors of early response may help optimize patient selection and management strategies. Objectives: To evaluate the predictive value of age, sex, baseline disease severity, and disease duration for early response to omalizumab and to assess their relationship with relapse risk. Methods: This retrospective study included 274 patients with CSU treated with omalizumab between 2011 and 2024. Early response was defined as achieving a UAS7 score <7 at one month. Baseline variables included age, sex, UAS7, and disease duration. Binary logistic regression and ROC curve analyses were conducted to identify independent predictors of early response. Results: Among 274 patients (mean age 42.96±15.54 years; 66.4% female), early response was achieved in 37.6%. Early responders had significantly lower baseline UAS7 and shorter disease duration (both P<0.001). Logistic regression confirmed both variables as independent predictors. Age and sex were not independently associated with early response, although univariate analysis showed a higher early response rate in patients aged <45 years. ROC analysis demonstrated strong inverse predictive value for UAS7 (AUC=0.917) and disease duration (AUC=0.940). Relapse risk was significantly lower in females and patients aged <45 years. Conclusions: Lower baseline UAS7 and shorter disease duration independently predict early response to omalizumab. Younger age and female sex may be associated with lower relapse risk. These findings support earlier therapeutic intervention in patients with lower disease burden to improve outcomes.
- 31 May 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (10) , 1989-1994
Serum raftlin and 8-isoprostaglandin F2α as potential biomarkers in seborrhoeic dermatitis: a case–control study
Background: Seborrhoeic dermatitis (SD) is a chronic inflammatory skin disorder associated with Malassezia species, immune dysregulation and potential oxidative stress. While previous studies have explored general inflammatory and oxidative mechanisms, specific biomarkers such as raftlin and 8-isoprostaglandin F2α (8-iso-PGF2α) have not yet been investigated in SD. Objectives: To evaluate serum raftlin and 8-iso-PGF2α levels in patients with SD and to determine their relationship with disease severity. Methods: This cross-sectional study included 50 patients with SD and 50 age- and sex-matched healthy controls. Disease severity was assessed using the Seborrheic Dermatitis Area and Severity Index. Serum raftlin and 8-iso-PGF2α levels were measured via the enzyme-linked immunosorbent assay. Statistical analyses included independent-samples t-tests, Spearman correlation and receiver operating characteristic (ROC) curve analysis. Results: Both raftlin and 8-iso-PGF2α levels were significantly higher in patients with SD than in controls (P < 0.001 for both). ROC analysis showed strong discriminatory performance for raftlin (area under the curve 0.987; cutoff 9.30 ng mL−1, 92% sensitivity, 100% specificity) and perfect accuracy for 8-iso-PGF2α (area under the curve 1.000; cutoff 27.9 pg mL−1, 100% sensitivity and specificity). No significant correlation was found between biomarker levels and disease severity. Conclusions: This study demonstrated that serum raftlin and 8-iso-PGF2α levels are significantly elevated in patients with seborrhoeic dermatitis compared with healthy controls. ROC curve analysis indicated strong discriminatory capacity, particularly for 8-iso-PGF2α, which achieved perfect sensitivity and specificity in this cohort. While these biomarkers are not specific to SD and reflect broader inflammatory and oxidative mechanisms, their strong discriminatory ability supports their potential role as adjunctive diagnostic indicators in clinical or research settings. Further validation in larger, multicentre cohorts is warranted to assess their utility across diverse populations and comorbid conditions.
- 31 May 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (10) , 1989-1994
Serum raftlin and 8-isoprostaglandin F2α as potential biomarkers in seborrhoeic dermatitis: a case–control study
Background: Seborrhoeic dermatitis (SD) is a chronic inflammatory skin disorder associated with Malassezia species, immune dysregulation and potential oxidative stress. While previous studies have explored general inflammatory and oxidative mechanisms, specific biomarkers such as raftlin and 8-isoprostaglandin F2α (8-iso-PGF2α) have not yet been investigated in SD. Objectives: To evaluate serum raftlin and 8-iso-PGF2α levels in patients with SD and to determine their relationship with disease severity. Methods: This cross-sectional study included 50 patients with SD and 50 age- and sex-matched healthy controls. Disease severity was assessed using the Seborrheic Dermatitis Area and Severity Index. Serum raftlin and 8-iso-PGF2α levels were measured via the enzyme-linked immunosorbent assay. Statistical analyses included independent-samples t-tests, Spearman correlation and receiver operating characteristic (ROC) curve analysis. Results: Both raftlin and 8-iso-PGF2α levels were significantly higher in patients with SD than in controls (P < 0.001 for both). ROC analysis showed strong discriminatory performance for raftlin (area under the curve 0.987; cutoff 9.30 ng mL−1, 92% sensitivity, 100% specificity) and perfect accuracy for 8-iso-PGF2α (area under the curve 1.000; cutoff 27.9 pg mL−1, 100% sensitivity and specificity). No significant correlation was found between biomarker levels and disease severity. Conclusions: This study demonstrated that serum raftlin and 8-iso-PGF2α levels are significantly elevated in patients with seborrhoeic dermatitis compared with healthy controls. ROC curve analysis indicated strong discriminatory capacity, particularly for 8-iso-PGF2α, which achieved perfect sensitivity and specificity in this cohort. While these biomarkers are not specific to SD and reflect broader inflammatory and oxidative mechanisms, their strong discriminatory ability supports their potential role as adjunctive diagnostic indicators in clinical or research settings. Further validation in larger, multicentre cohorts is warranted to assess their utility across diverse populations and comorbid conditions.
- 11 April 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-9
Low-density lipoprotein receptor-related protein-1 and nitrative stress in psoriasis vulgaris: a cross-sectional study
Hyperlipidemia is a risk factor for cardiovascular diseases, and low serum lipid levels may play a protective role. Low-density lipoprotein receptor-related protein-1 (LRP1) is a receptor involved in lipid metabolism, cellular signal transduction, and inflammation processes. Nitrosative stress (NO, 3-NT) may also contribute to the pathophysiology of dermatological diseases. To date, no published study has investigated the concentrations of nitrosative stress biomarkers, such as 3-NT and NO, along with LRP1 levels in patients with psoriasis vulgaris. This study aims to assess the relationship between lipid profiles, nitrosative stress markers (NO, 3-NTx), and LRP1 levels with disease severity in psoriasis vulgaris patients. The study included 50 patients with psoriasis vulgaris and 50 healthy individuals. Serum lipid profiles (total cholesterol, triglycerides, LDL, HDL, VLDL) were measured using a colorimetric enzyme method on an autoanalyzer, while NO, 3-NTx, and LRP1 levels were determined via ELISA. The severity of psoriasis was evaluated using the Psoriasis Area Severity Index (PASI). Data on disease duration, medication use, smoking, alcohol consumption, and weight were recorded. Total cholesterol, triglyceride, and LDL levels were significantly higher in psoriasis vulgaris patients compared to healthy controls (p < 0.05). Increased NO and 3-NTx levels were identified as indicators of oxidative stress. A positive correlation was found between LRP1, NO, 3-NTx levels, and PASI scores. Altered lipid profiles and increased oxidative stress in psoriasis vulgaris patients are associated with cardiovascular risk. The correlation between LRP1, NO, and 3-NTx levels and disease severity suggests that these biomarkers may serve as potential monitoring tools in psoriasis management. Further studies are needed to determine their therapeutic and clinical significance.
- 11 April 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-9
Low-density lipoprotein receptor-related protein-1 and nitrative stress in psoriasis vulgaris: a cross-sectional study
Hyperlipidemia is a risk factor for cardiovascular diseases, and low serum lipid levels may play a protective role. Low-density lipoprotein receptor-related protein-1 (LRP1) is a receptor involved in lipid metabolism, cellular signal transduction, and inflammation processes. Nitrosative stress (NO, 3-NT) may also contribute to the pathophysiology of dermatological diseases. To date, no published study has investigated the concentrations of nitrosative stress biomarkers, such as 3-NT and NO, along with LRP1 levels in patients with psoriasis vulgaris. This study aims to assess the relationship between lipid profiles, nitrosative stress markers (NO, 3-NTx), and LRP1 levels with disease severity in psoriasis vulgaris patients. The study included 50 patients with psoriasis vulgaris and 50 healthy individuals. Serum lipid profiles (total cholesterol, triglycerides, LDL, HDL, VLDL) were measured using a colorimetric enzyme method on an autoanalyzer, while NO, 3-NTx, and LRP1 levels were determined via ELISA. The severity of psoriasis was evaluated using the Psoriasis Area Severity Index (PASI). Data on disease duration, medication use, smoking, alcohol consumption, and weight were recorded. Total cholesterol, triglyceride, and LDL levels were significantly higher in psoriasis vulgaris patients compared to healthy controls (p < 0.05). Increased NO and 3-NTx levels were identified as indicators of oxidative stress. A positive correlation was found between LRP1, NO, 3-NTx levels, and PASI scores. Altered lipid profiles and increased oxidative stress in psoriasis vulgaris patients are associated with cardiovascular risk. The correlation between LRP1, NO, and 3-NTx levels and disease severity suggests that these biomarkers may serve as potential monitoring tools in psoriasis management. Further studies are needed to determine their therapeutic and clinical significance.
- Open Access
- 7 March 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (10) , e41747
Can the count and percentage of immature granulocytes be used to detect disease activity in patients with pemphigus?: A preliminary study
Recently, immature granulocyte count (IGC) in an automated blood cell counter was introduced as a new inflammatory marker. We aimed to evaluate the relationship between the IGC and percentage of immature granulocyte (IG%) and disease activity in patients with pemphigus. Pemphigus disease area index (PDAI), IGC, IG%, C-reactive protein, neutrophil/lymphocyte ratios, platelet-to-lymphocyte ratio (PLR), anti-desmoglein 1, and anti-desmoglein 3 levels in patients with pemphigus were recorded retrospectively, and the statistical relationship between them was evaluated. Repetitive intra-patient blood samples (74 blood samples) and PDAIs (74 PDAI scores) of 24 patients (12 men, 12 women; mean age 56.30 ± 16.47 years) were included in the study. There was no correlation between PDAI and anti-desmoglein 1, anti-desmoglein 3 levels, and neutrophil/lymphocyte ratio (r = 0.040, P = .737; r = 0.007, P = .952; r = 0.224, P = .055, respectively). A statistically low positive correlation was detected between PDAI and C-reactive protein (r = 0.243, P = .037). There was a moderate positive correlation between PDAI and IGC, IG%, and PLR (r = 0.435, P < .001; r = 0.412, P < .001; r = 0.376, P = .001, respectively). The effects of independent variables in predicting PDAI were evaluated using multiple linear regression analysis. Accordingly, the cutoff value of the IGC and PLR positively significantly affect the PDAI score (P < .05). A 1-unit increase in PLR indicates a 0.009 times increase in PDAI, and a 1-unit increase exceeding the IG cutoff value indicates a 2.836 times increase in PDAI. The IGC and IG% can be used to evaluate pemphigus disease activity.
- 7 March 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (10) , e41747
Open AccessCan the count and percentage of immature granulocytes be used to detect disease activity in patients with pemphigus?: A preliminary study
Recently, immature granulocyte count (IGC) in an automated blood cell counter was introduced as a new inflammatory marker. We aimed to evaluate the relationship between the IGC and percentage of immature granulocyte (IG%) and disease activity in patients with pemphigus. Pemphigus disease area index (PDAI), IGC, IG%, C-reactive protein, neutrophil/lymphocyte ratios, platelet-to-lymphocyte ratio (PLR), anti-desmoglein 1, and anti-desmoglein 3 levels in patients with pemphigus were recorded retrospectively, and the statistical relationship between them was evaluated. Repetitive intra-patient blood samples (74 blood samples) and PDAIs (74 PDAI scores) of 24 patients (12 men, 12 women; mean age 56.30 ± 16.47 years) were included in the study. There was no correlation between PDAI and anti-desmoglein 1, anti-desmoglein 3 levels, and neutrophil/lymphocyte ratio (r = 0.040, P = .737; r = 0.007, P = .952; r = 0.224, P = .055, respectively). A statistically low positive correlation was detected between PDAI and C-reactive protein (r = 0.243, P = .037). There was a moderate positive correlation between PDAI and IGC, IG%, and PLR (r = 0.435, P < .001; r = 0.412, P < .001; r = 0.376, P = .001, respectively). The effects of independent variables in predicting PDAI were evaluated using multiple linear regression analysis. Accordingly, the cutoff value of the IGC and PLR positively significantly affect the PDAI score (P < .05). A 1-unit increase in PLR indicates a 0.009 times increase in PDAI, and a 1-unit increase exceeding the IG cutoff value indicates a 2.836 times increase in PDAI. The IGC and IG% can be used to evaluate pemphigus disease activity.
- Open Access
- 29 January 2025
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 15 (1) , 4969
Evaluation of the Effects of systemic Therapy on Inflammatory Markers and Disease Severity in Patients With Pemphigus
Introduction: In recent years, various inflammatory markers that can change in inflammatory states have been investigated. On the basis of these, we thought that inflammatory markers could also be used in the treatment of pemphigus disease and monitoring its activity. Objective: In this study, our objective was to investigate changes in the inflammatory markers NLR, PLR, MPV, LMR, CRP and ESR, which are inflammatory markers, before treatment and during follow-up, and the correlation of disease severity with these markers in patients with pemphigus receiving IVIG and/or systemic immunosuppressant agents. Method: 76 pemphigus patients who received systemic treatment, and used these treatments for at least 6 months were included. Changes in NLR, PLR, LMR, MPV, CRP and sedimentation values were examined in patients who received systemic treatment for at least 6 months, before the start of treatment and 3 and 6 months after the start of treatment. Results: Significant changes in inflammatory markers and correlation values were found in all patients. Conclusions: We think that neutrophil, platelet, NLR and PLR values can be used to monitor the response to treatment in pemphigus, since they show a significant decrease with treatment and are significantly positively correlated with PDAI, which indicates the severity of the disease. LMR values were indicators of a poor prognosis. We found that the duration of remission was longer in the group receiving IVIg. Although there was no difference between the treatments in terms of disease recovery, only IVIg prolonged the duration of remission.
- 29 January 2025
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 15 (1) , 4969
Open AccessEvaluation of the Effects of systemic Therapy on Inflammatory Markers and Disease Severity in Patients With Pemphigus
Introduction: In recent years, various inflammatory markers that can change in inflammatory states have been investigated. On the basis of these, we thought that inflammatory markers could also be used in the treatment of pemphigus disease and monitoring its activity. Objective: In this study, our objective was to investigate changes in the inflammatory markers NLR, PLR, MPV, LMR, CRP and ESR, which are inflammatory markers, before treatment and during follow-up, and the correlation of disease severity with these markers in patients with pemphigus receiving IVIG and/or systemic immunosuppressant agents. Method: 76 pemphigus patients who received systemic treatment, and used these treatments for at least 6 months were included. Changes in NLR, PLR, LMR, MPV, CRP and sedimentation values were examined in patients who received systemic treatment for at least 6 months, before the start of treatment and 3 and 6 months after the start of treatment. Results: Significant changes in inflammatory markers and correlation values were found in all patients. Conclusions: We think that neutrophil, platelet, NLR and PLR values can be used to monitor the response to treatment in pemphigus, since they show a significant decrease with treatment and are significantly positively correlated with PDAI, which indicates the severity of the disease. LMR values were indicators of a poor prognosis. We found that the duration of remission was longer in the group receiving IVIg. Although there was no difference between the treatments in terms of disease recovery, only IVIg prolonged the duration of remission.
- 5 October 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 316 (9) , 1-7
Evaluation of the relationship between serum G protein-coupled estrogen receptors (GPER-1) levels and the severity and duration of the disease in patients with androgenetic alopecia: A case-control study
There are studies revealing the effects of estrogen receptors alpha (α) and beta (β) on hair follicles. However, the effects of G protein-coupled estrogen receptors (GPER-1) on hair follicles have not been elucidated. This study aims to evaluate the relationship between serum GPER-1 levels and the severity and duration of the disease in patients with androgenetic alopecia (AGA). The study included 81 patients with AGA aged 18 to 50 years (22 men and 19 women with an onset of AGA more than 5 years, and 20 men and 20 women with an onset of AGA less than 5 years) and 40 healthy controls (20 men, 20 women). The mean age of participants with AGA was 29.12 ± 8.15 (18-50), and the mean age of the control group was 25.21± 4.71 (19-42). Serum GPER-1 levels were measured, and the relationship between GPER-1 levels and duration of the disease, severity of the disease, and sex was statistically evaluated. The serum level of GPER-1 was significantly higher in patients with AGA as compared to the control group (p < 0.001). A negative correlation was found between serum GPER-1 levels and the duration of the disease in both men and women (p < 0.001, r = 0.793; p < 0.001, r = 0.711, respectively). There was a significant relationship between serum GPER-1 levels and the severity of the disease in both men and women (p = 0.003; p = 0.002, respectively). Additionally, a significant difference in GPER-1 levels was noted between male and female patients with AGA (p = 0.001). However, no statistically significant relationship was identified between GPER-1 levels and estrogen levels (p = 0.097). The higher levels of GPER-1 in patients with AGA compared to the control group, and the significant relationship between GPER-1 levels and both the duration and severity of the disease, suggest an estrogen-independent role of GPER-1 in the pathogenesis of AGA. The fact that GPER-1 levels are high in the early stages of AGA when inflammation is prominent suggests that treatments targeting these receptors may be effective at this stage.
- 5 October 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 316 (9) , 1-7
Evaluation of the relationship between serum G protein-coupled estrogen receptors (GPER-1) levels and the severity and duration of the disease in patients with androgenetic alopecia: A case-control study
There are studies revealing the effects of estrogen receptors alpha (α) and beta (β) on hair follicles. However, the effects of G protein-coupled estrogen receptors (GPER-1) on hair follicles have not been elucidated. This study aims to evaluate the relationship between serum GPER-1 levels and the severity and duration of the disease in patients with androgenetic alopecia (AGA). The study included 81 patients with AGA aged 18 to 50 years (22 men and 19 women with an onset of AGA more than 5 years, and 20 men and 20 women with an onset of AGA less than 5 years) and 40 healthy controls (20 men, 20 women). The mean age of participants with AGA was 29.12 ± 8.15 (18-50), and the mean age of the control group was 25.21± 4.71 (19-42). Serum GPER-1 levels were measured, and the relationship between GPER-1 levels and duration of the disease, severity of the disease, and sex was statistically evaluated. The serum level of GPER-1 was significantly higher in patients with AGA as compared to the control group (p < 0.001). A negative correlation was found between serum GPER-1 levels and the duration of the disease in both men and women (p < 0.001, r = 0.793; p < 0.001, r = 0.711, respectively). There was a significant relationship between serum GPER-1 levels and the severity of the disease in both men and women (p = 0.003; p = 0.002, respectively). Additionally, a significant difference in GPER-1 levels was noted between male and female patients with AGA (p = 0.001). However, no statistically significant relationship was identified between GPER-1 levels and estrogen levels (p = 0.097). The higher levels of GPER-1 in patients with AGA compared to the control group, and the significant relationship between GPER-1 levels and both the duration and severity of the disease, suggest an estrogen-independent role of GPER-1 in the pathogenesis of AGA. The fact that GPER-1 levels are high in the early stages of AGA when inflammation is prominent suggests that treatments targeting these receptors may be effective at this stage.
- Open Access
- 2 May 2023
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 22 (10) , 2791-2798
Dermatoses in overweight and obese children and their relationship with insulin and skin color
Background/Aim: The aim of the present study was to investigate the prevalence of obesity‐related dermatoses in obese children, and the association between these dermatoses and insulin resistance as well as skin color.Methods: Obese, overweight, and normal weight children according to body mass index who were followed up and treated in the outpatient clinics were included in the study. Dermatological examinations of the participants were performed, and fasting insulin and glucose levels were checked.Results: The obese and overweight children were evaluated as the patient group (70 girls, 41 boys, mean age: 12.37 ± 3.14 years). One hundred one healthy children with normal weight were determined as the control group (59 girls, 42 boys, mean age: 12.15 ± 2.43). The first five common dermatoses in the patient group when compared with the control group were keratosis pilaris (KP), striae distensae, hyperhidrosis, acanthosis nigricans (AN), and plantar hyperkeratosis. The first five dermatoses which were positively correlated with formation and insulin resistance were KP, striae distensae, AN, hyperhidrosis, and plantar hyperkeratosis. According to the Fitzpatrick skin scale, we found that the darker the skin color, the higher the probability of AN and KP (OR, 0.298; 95% CI, 0.106–0.834, p = 0.021; OR, 0.306; 95% CI, 0.117–0.796, p = 0.015, respectively).Conclusion: Some dermatoses associated with obesity and insulin resistance were not found in obese children, or there was no significant association. These results indicate that many skin morbidities may be prevented by preventing and treating obesity and insulin resistance in the early period.
- 2 May 2023
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 22 (10) , 2791-2798
Open AccessDermatoses in overweight and obese children and their relationship with insulin and skin color
Background/Aim: The aim of the present study was to investigate the prevalence of obesity‐related dermatoses in obese children, and the association between these dermatoses and insulin resistance as well as skin color.Methods: Obese, overweight, and normal weight children according to body mass index who were followed up and treated in the outpatient clinics were included in the study. Dermatological examinations of the participants were performed, and fasting insulin and glucose levels were checked.Results: The obese and overweight children were evaluated as the patient group (70 girls, 41 boys, mean age: 12.37 ± 3.14 years). One hundred one healthy children with normal weight were determined as the control group (59 girls, 42 boys, mean age: 12.15 ± 2.43). The first five common dermatoses in the patient group when compared with the control group were keratosis pilaris (KP), striae distensae, hyperhidrosis, acanthosis nigricans (AN), and plantar hyperkeratosis. The first five dermatoses which were positively correlated with formation and insulin resistance were KP, striae distensae, AN, hyperhidrosis, and plantar hyperkeratosis. According to the Fitzpatrick skin scale, we found that the darker the skin color, the higher the probability of AN and KP (OR, 0.298; 95% CI, 0.106–0.834, p = 0.021; OR, 0.306; 95% CI, 0.117–0.796, p = 0.015, respectively).Conclusion: Some dermatoses associated with obesity and insulin resistance were not found in obese children, or there was no significant association. These results indicate that many skin morbidities may be prevented by preventing and treating obesity and insulin resistance in the early period.
- 1 March 2023
- Published by ASEAN Neurological Association in Neurology Asia
- Vol. 28 (1) , 221-225
Can isotretinoin be used in treating multiple neurofibromas thanks to its apoptotic effect?
- 1 March 2023
- Published by ASEAN Neurological Association in Neurology Asia
- Vol. 28 (1) , 221-225
Can isotretinoin be used in treating multiple neurofibromas thanks to its apoptotic effect?
- Open Access
- 22 March 2022
- Published by Galenos Yayinevi in TURKDERM
- Vol. 56 (1) , 42-45
Pityriasis rubra pilaris developing after COVID-19
- 22 March 2022
- Published by Galenos Yayinevi in TURKDERM
- Vol. 56 (1) , 42-45
Open AccessPityriasis rubra pilaris developing after COVID-19